A Theoretical Coupled Poisson–Nernst–Planck–Reaction Field Model for Generalised Ionisable Drug Pharmacokinetics with Self-Consistent Solvation, Dynamic pH Microenvironments, Electrokinetic Drift, Ionic Clustering, Thermodynamic Variational Consistency, and Full Covariance Mesh Analysis

Read full text Summarise with VIRAT
Authors: Lance Thomas Davidson
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

SYNOPSIS This dissertation establishes a unified, deterministic, field-theoretic pharmacokinetic framework for ionisable drugs, constructed to eliminate reliance on empirically fitted compartmental approximations and instead derive all transport, transformation, and interaction processes from first principles. The model is formulated as a fully coupled system of nonlinear partial differential equations over a fourteen-component state vector, capturing spatial–temporal evolution of drug concentration, charge-state speciation, electrostatic potential, hydration structure, ionic association, redox modulation, metabolite formation, and pharmacodynamic response. At its core, the framework enforces thermodynamic consistency through the Energetic Variational Approach (EnVarA), ensuring that all fluxes, forces, and dissipation mechanisms arise from a unified free-energy and dissipation functional. This eliminates circular dependencies commonly present in traditional pharmacokinetic models and guarantees internal coherence between transport, reaction kinetics, and electrochemical interactions. The model introduces endogenous transport coefficients, where diffusivity, drift velocity, and elimination rates are not prescribed constants but emergent functions of the internal fields, particularly hydration order (H), ionic association (I), electrostatic potential (φ), and local charge distributions. This creates a closed-loop system in which the evolving state directly governs its own transport behaviour, yielding non-linear feedback structures absent in classical PK formulations. Charge-state speciation is dynamically resolved through relaxation toward Henderson–Hasselbalch equilibria under spatially varying pH microenvironments, themselves governed by proton transport equations. This introduces a fully endogenous pH field, coupling acid–base chemistry with electrostatics and diffusion. The electrostatic potential is computed through a Poisson field equation driven by charge asymmetry, enabling self-generated electrophoretic transport. Hydration and ionic association fields act as structural order parameters encoding solvent organization and clustering phenomena. These fields directly modulate diffusivity, solubility, and elimination kinetics, producing a physically grounded representation of solvation effects. Supersaturation dynamics are explicitly tracked, linking thermodynamic stability to precipitation risk and bioavailability constraints. The framework is extended through eight generalising modules, including multi-state ion ladders, virial interaction corrections, tensorial diffusivity, metabolite field coupling, endogenous boundary conditions, competitive solvation, pharmacodynamic Hill feedback, and covariance mesh formalism. These extensions demonstrate that the core architecture is not a special-case model but a universal scaffold capable of incorporating additional biochemical and physical complexities without structural modification. Further chapters develop applied implications, including rational drug design via parameter optimization, temperature and dielectric coupling, oxidative stress interactions, and uncertainty quantification. A computational layer integrates GPU-accelerated solvers, stochastic perturbations for inter-patient variability, AI-assisted closure models, and multiscale molecular dynamics coupling. The resulting system constitutes a deterministic, non-circular, thermodynamically grounded pharmacokinetic theory that replaces empirical fitting with predictive, physically derived dynamics. While presented as a theoretical construct, the framework is explicitly structured to generate testable predictions and to serve as a foundation for experimental validation and computational implementation. ALTERNATIVE TITLES A Thermodynamically Consistent Field Framework for Ionisable Drug Pharmacokinetics with Endogenous Transport Dynamics Nonlinear Field-Coupled Pharmacokinetics: A Deterministic PDE Architecture for Ionisable Drug Transport and Interaction Endogenous Transport and Thermodynamic Closure in Pharmacokinetics: A Unified Field-Theoretic Model for Ionisable Compounds ROADMAP FOR THE READER This thesis presents a comprehensive theoretical framework for ionisable drug pharmacokinetics that integrates fourteen coupled field variables and eight generalising extensions within a single, internally consistent architecture. While the full scope is deliberately ambitious, it is the minimal set required to achieve non-circular closure, thermodynamic consistency via the Energetic Variational Approach, and fully endogenous transport coefficients. The structure is therefore designed to allow engagement at multiple levels of depth without loss of coherence. Recommended Reading Path Chapters 1–5These chapters establish the foundational architecture: motivation, axiomatic framework, state vector definition, governing field equations, and thermodynamic closure via the Energetic Variational Approach. This segment constitutes the irreducible core and may be read independently as a complete theoretical introduction to the field-based pharmacokinetic paradigm. Chapters 6–12This section develops the full coupled PDE system in explicit derivational detail. It includes charge-state speciation, dynamic pH microenvironments, hydration-order parameter H, ionic-association field I, endogenous transport coefficients (D(H,I), v(H,φ), k_elim, S_eff), and formal stability analysis with internal invariants. Completion of this section yields the fully operational core model. Chapters 13–22These chapters introduce the eight generalising extensions: the N-state Bjerrum ladder, virial interaction corrections, tensor diffusivity, metabolite field coupling, endogenous boundary conditions, competitive solvation, PK–PD Hill feedback integration, and the covariance mesh formalism. Each extension is derived directly from the core system, demonstrating structural universality rather than ad hoc augmentation. Chapters 23–28This section explores applied implications and physical extensions, including rational drug design pathways, temperature and dielectric coupling, reactive oxygen species interactions, uncertainty quantification, and a structured experimental validation roadmap. These chapters translate the theoretical system into testable and practical domains. Chapters 29–32Advanced computational implementations are presented here, including AI-assisted closure approximation, stochastic extensions for inter-individual variability, multiscale hybrid molecular dynamics–continuum coupling, and CUDA-based GPU acceleration with skeletonised pseudocode reflecting full system integration. Chapter 33The final chapter provides a complete synthesis of the theoretical framework, summarising its internal consistency, predictive capacity, and implications for the future of pharmacokinetic modelling. Structural Note Cross-references and dependency topology mappings are provided throughout (see Chapter 3.2), enabling non-linear navigation of the document while preserving logical continuity. The uniform theoretical language convention ensures that all propositions remain consistent with available empirical knowledge while extending into predictive, experimentally testable regimes. The complexity of the framework is not ornamental but necessary. Each variable and extension is required to maintain thermodynamic consistency, eliminate circular dependencies, and ensure that all transport coefficients arise endogenously from the system itself.

Fields of Study & Subjects

Computational Drug Discovery Methods Pharmacogenetics and Drug Metabolism Electrostatics and Colloid Interactions

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
26 March 2026
Language
EN
Document type
Thesis